A randomized controlled trial of smoking cessation treatment for young adult dual users of combustible and electronic cigarettes
对同时使用可燃烟和电子烟的年轻成人进行戒烟治疗的随机对照试验
基本信息
- 批准号:10285534
- 负责人:
- 金额:$ 18.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-29 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAcuteAdultAdverse eventBehaviorCigarette SmokerElectronic cigaretteHealthLifeNicotineNicotine DependenceOutcomeParticipantPopulationPrevalencePublishingRandomizedRandomized Controlled TrialsResearchSmokeSmokerSmokingSmoking Cessation InterventionTestingText MessagingTobaccoUnited StatesVermontbasecigarette smokingcombustible cigaretteeffectiveness testingelectronic cigarette useelectronic cigarette userfollow-upmortalitynicotine replacementprimary outcomesmoking cessationyoung adult
项目摘要
Over 480,000 people die per year from combustible cigarette (CC) smoking related illness in the
United States. Young adults are particularly vulnerable to nicotine dependence and harm from tobacco.
The prevalence of electronic cigarette (EC) use has increased exponentially over the past decade and
is highest among young adults. ECs could substantially reduce harm for young adult smokers who
completely switch from CCs to ECs and remain abstinent from CCs. However, most who use ECs
continue to smoke CCs (i.e., dual users), which could perpetuate nicotine dependence and harm from
CC smoking. There are no empirically based treatments for dual users and it is unclear whether quitting
CCs only or quitting both CCs and ECs simultaneously is more effective to achieve long-term
abstinence from CCs. Nicotine replacement therapy (NRT) is an effective first-line smoking cessation
treatment for adult CC smokers but has never been tested among young adults or among dual users.
Given the strong evidence that smoking cessation early in life can completely avoid tobacco-related
mortality, there is a need to test effective smoking cessation treatment for young adult dual users.
The overarching aim of the proposed 2x2 factorial RCT is to test NRT with text message support for
two smoking cessation approaches among young adult dual users of CCs and ECs. Specifically, we
aim to 1) test the effectiveness of NRT for CC cessation among young adult dual users and 2) test
whether quitting CCs only versus quitting CCs and ECs simultaneously is more effective to achieve CC
abstinence. Participants (n=390) will be randomized to receive A) NRT plus text messages to quit CCs
only, B) NRT plus text messages to quit CCs and ECs simultaneously, C) text messages alone to quit
CCs only, or D) text messages alone to quit CCs and ECs simultaneously. Our primary outcome will be
CO-verified 7-day point-prevalence abstinence at the end of treatment (i.e., 3 months after
randomization).
Findings from our primary aims will directly inform smoking cessation treatment for young adult dual
users, a population that is particularly vulnerable to the harmful effects of nicotine addiction. This is
important given the current lack of published research on smoking cessation treatment for dual users or
NRT for young adults. As secondary aims, we will explore the interaction between NRT use versus no
use and quitting CCs only versus CCs and ECs simultaneously as well as change in nicotine
dependence, demand, and other smoking related outcomes among participants who fail to quit.
Broadly, findings will have applied implications for treating young adult dual users and scientific
implications regarding the effects of quitting one (CCs) versus two (CCs and ECs) nicotine products
simultaneously.
在美国,每年有超过48万人死于与吸烟有关的疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elias Mushabac Klemperer其他文献
Elias Mushabac Klemperer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elias Mushabac Klemperer', 18)}}的其他基金
A randomized controlled trial of smoking cessation treatment for young adult dual users of combustible and electronic cigarettes
对同时使用可燃烟和电子烟的年轻成人进行戒烟治疗的随机对照试验
- 批准号:
10292910 - 财政年份:2013
- 资助金额:
$ 18.21万 - 项目类别:
A randomized controlled trial of smoking cessation treatment for young adult dual users of combustible and electronic cigarettes
对同时使用可燃烟和电子烟的年轻成人进行戒烟治疗的随机对照试验
- 批准号:
10491323 - 财政年份:2013
- 资助金额:
$ 18.21万 - 项目类别:
相似海外基金
Un/kindness, shame & resistance: the care of inpatients in NHS adult acute mental health units and how it might be improved
Un/善良,羞耻
- 批准号:
2885806 - 财政年份:2023
- 资助金额:
$ 18.21万 - 项目类别:
Studentship
Post-Acute Care Transitions for Older Adult Medicare Beneficiaries with Serious Mental Illness
患有严重精神疾病的老年医疗保险受益人的急性后护理过渡
- 批准号:
10772386 - 财政年份:2023
- 资助金额:
$ 18.21万 - 项目类别:
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
474619 - 财政年份:2022
- 资助金额:
$ 18.21万 - 项目类别:
Operating Grants
Investigating the impact acute inhalation of cannabis with a high content of delta-9-tetrahydrocannabinol has on myelination and microglia in adult and aged mice
研究急性吸入高含量 delta-9-四氢大麻酚的大麻对成年和老年小鼠髓鞘形成和小胶质细胞的影响
- 批准号:
485965 - 财政年份:2022
- 资助金额:
$ 18.21万 - 项目类别:
Studentship Programs
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
466358 - 财政年份:2022
- 资助金额:
$ 18.21万 - 项目类别:
Operating Grants
Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study
预测顺铂介导的急性肾损伤的代谢组学:加拿大多中心成人和儿童研究
- 批准号:
402040 - 财政年份:2019
- 资助金额:
$ 18.21万 - 项目类别:
Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
- 批准号:
18K16103 - 财政年份:2018
- 资助金额:
$ 18.21万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Causal effect of time-varying driving pressures on mortality in mechanically ventilated, adult patients with acute respiratory distress syndrome
时变驱动压力对机械通气成年急性呼吸窘迫综合征患者死亡率的因果影响
- 批准号:
377313 - 财政年份:2017
- 资助金额:
$ 18.21万 - 项目类别:
Studentship Programs
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
SETBP1 在成人 Ph 急性淋巴细胞白血病中的作用
- 批准号:
9315111 - 财政年份:2016
- 资助金额:
$ 18.21万 - 项目类别:
Acute Inhibition of Adult-born Granule Cells and its Effect on Antidepressant Act
成体颗粒细胞的急性抑制及其抗抑郁作用
- 批准号:
8734273 - 财政年份:2013
- 资助金额:
$ 18.21万 - 项目类别: